Therapeutic Inertia in Pharmacologic Dose Optimization: Prevalence, Clinical Consequences, and Economic Burden Across Sixteen Chronic Conditions

Failure to titrate medications to guideline-recommended target doses is widespread across sixteen chronic conditions and carries substantial clinical and economic costs.

Sign up for our newsletter.

Get our clinical outcomes, case studies, new AI agents, LLM updates, and more in your inbox.